Success Story: Thanks To Our Firm’s Assistance, NIW Approval for a Neuroscience Researcher From Spain Without RFE

 

Client’s Testimonial:

"I decided to work with the North America Immigration group for 2 reasons: they seemed the best team, and they were very responsive, very fast at answering questions, even before I decided to finally retain them. To me, it was an easy decision. Since the beginning, I could tell they had a system and tons of experience, and that brought me so much peace of mind. They were diligent, clear, and easy to work with. They worked hard to present the strongest case possible. And we succeeded. I recommend them 100%."

---

On February 17^th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Associate in the Field of Neuroscience (Approval Notice).

---

General Field: Neuroscience

Position at the Time of Case Filing: Postdoctoral Research Associate

Country of Origin: Spain

State of Residence at the Time of Filing: North Carolina

Approval Notice Date: February 17^th, 2026

Processing Time: 11 months, 24 days

---

Case Summary:  

It was a privilege for our team to assist a neuroscience researcher with a Ph.D. in biomedicine through an EB-2 NIW (National Interest Waiver) petition. Drawing on our extensive experience and a proven track record of over 32,000 successful cases, we developed a clear, evidence-driven filing that presented both the national importance of the client’s work and the client’s strong positioning to advance it.

Building the Foundation

The client currently conducts neuroscience research in the United States and focuses on a critical challenge in modern medicine: understanding how mutations in autism-related genes can lead to severe and rare neurodevelopmental disorders, including Angelman syndrome, and translating that knowledge into practical therapeutic strategies. The proposed endeavor is to continue using mouse models and human cell lines to define disease mechanisms and to apply CRISPR/Cas9 genome editors to develop state-of-the-art gene therapy strategies delivered to the brain through both viral and non-viral systems, including adeno-associated viruses and lipid nanoparticles.

From the outset, we framed the endeavor as an area of clear, substantial merit and national importance because it targets conditions with profound lifelong impacts on patients and families, where improved mechanistic understanding is essential to developing effective therapies. Rather than relying on broad assertions, we emphasized how the client’s approach connects rigorous model-based discovery to translational gene-therapy design, which is the kind of research pathway that can move a field toward meaningful clinical options.

We documented the client’s record using objective indicators that an adjudicator can evaluate:

• Publications: 6 peer-reviewed journal articles (2 first-authored) and 7 abstracts (6 first-authored)
• Citations: 61 citations to the client’s published work
• Peer review service: at least 2 completed reviews
• Competitive support: evidence of major funding sources supporting the research direction

Rather than presenting these metrics as merely self-evident, we translated them into a clear narrative of impact. The citation record was presented as evidence of independent reliance, meaning other researchers have used the client’s findings to inform and validate their own studies. We also highlighted that one of the client’s publications achieved top-percentile citation performance for its field and publication year, which helps normalize impact across time and discipline rather than relying on raw counts alone. Separately, peer review activity was positioned as a trust signal, since journals generally invite reviewers who have demonstrated specialized expertise and sound technical judgment.

To clearly illustrate the client’s influence, we connected the record to concrete research outputs, including work that advanced understanding of neurodevelopmental mechanisms, introduced a tool-like approach for tracking cell fate and enabling targeted gene manipulation, and clarified cellular transport and organization processes that are relevant to biology across systems. We also included evidence of a major professional award in gene and cell therapy as an additional marker of peer recognition.

Expert Endorsements

The petition was further supported by 2 recommendation letters from experts familiar with the client’s work. These letters reinforced the objective record by explaining why the client’s research direction and technical skill set matter to the field and why the work is positioned to generate continuing benefits in the United States. For example, one expert noted:

 “Therefore, [Client’s] review service illustrates her recognition as an expert in the neuroscience research community.”

NIW Approval and Outlook

This NIW approval reflects USCIS’s recognition that the client’s proposed endeavor has substantial merit and national importance, and that the client is well-positioned to advance it through a demonstrated publication record, independent citation uptake, and trusted contributions as a peer reviewer, supported by competitive research funding and strong expert testimony. We look forward to the client’s continued progress in developing advanced, mechanism-driven gene therapy strategies that can improve the understanding, diagnosis, and treatment pathways for severe neurodevelopmental disorders.